Polar Capital Holdings’s Biogen BIIB Stock Holding History

Polar Capital Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-225,000	Closed	-$52.2M	–	296
2024 Q2	$52.2M	Sell	225,000 -75,000	-25%	-$16.3M	0.31%	80
2024 Q1	$64.7M	Hold	300,000	–	–	0.34%	73
2023 Q4	$77.6M	Hold	300,000	–	–	0.48%	60
2023 Q3	$77.1M	Sell	300,000 -25,000	-8%	-$6.69M	0.57%	52
2023 Q2	$92.6M	Buy	325,000 +75,000	+30%	+$22.3M	0.47%	49
2023 Q1	$69.5M	Buy	250,000 +100,000	+67%	+$27.7M	0.45%	64
2022 Q4	$41.5M	Sell	150,000 -100,000	-40%	-$28.2M	0.33%	91
2022 Q3	$66.8M	Buy	250,000 +75,000	+43%	+$15.9M	0.43%	63
2022 Q2	$35.7M	Buy	175,000 +50,000	+40%	+$10.2M	0.21%	101
2022 Q1	$26.3M	Sell	125,000 -25,000	-17%	-$5.44M	0.12%	143
2021 Q4	$36M	Buy	150,000 +25,000	+20%	+$6.43M	0.14%	125
2021 Q3	$35.4M	Hold	125,000	–	–	0.14%	128
2021 Q2	$43.3M	Sell	125,000 -75,000	-38%	-$22.7M	0.19%	111
2021 Q1	$56M	Buy	200,000 +50,000	+33%	+$13.5M	0.35%	86
2020 Q4	$36.7M	Buy	+150,000	New	+$38.7M	0.22%	108

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Polar Capital Holdings's BIIB Position: Q3 2024 in Review

Polar Capital Holdings sold out of Biogen (BIIB) in Q3 2024, closing a stake of 225,000 shares — an estimated $52.2M sold.

Polar Capital Holdings first reported a position in BIIB in Q4 2020 and held it in 15 quarters. The position peaked at $92.6M in Q2 2023. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

Polar Capital Holdings reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
Polar Capital Holdings sold 225,000 Biogen shares in Q3 2024, an estimated $52.2M.
Polar Capital Holdings first reported a position in Biogen in Q4 2020 and held it in 15 quarters.
Polar Capital Holdings's Biogen position peaked at $92.6M in Q2 2023.
917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Polar Capital Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.